GPCR News 

Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist

Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...

First in Human: Early-stage COVID therapies hold promise against omicron variant

OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...

Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...

Genome-wide identification of 216 G protein-coupled receptor (GPCR) genes from the marine water ...

Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets

Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...

Dr. Thomas P. Sakmar receives an honorary doctorate from Karolinska Institute

Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...

Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19...

Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European ...

Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team

Newly launched antibody libraries put hard-to-drug targets within reach

Search for safer pain relief advances with new engineered compounds

Dr. Alexander S. Hauser receives the Bachem award for peptide science

California gold rush for Sosei Heptares

Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in ...